Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

31/07/2026 04:00

   Jul 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              116.16              127.54           455.00    
                   (-8.9 pct)          (+8.4 pct)       (-11.8 pct) 
  Operating           30.65               22.00            94.00    
                   (+39.4 pct)         (-28.3 pct)      (+1.9 pct)  
  Pretax              31.25               22.65            94.00    
                   (+38.0 pct)         (-32.0 pct)      (+1.5 pct)  
  Net                 24.15               17.67            71.00    
                   (+36.7 pct)         (-28.7 pct)      (+1.8 pct)  
  EPS Basic         51.40 yen           37.62 yen       151.09 yen  
  EPS Diluted       51.38 yen           37.58 yen                   
  Ann Div                               80.00 yen        80.00 yen  
  -Q2 Div                               40.00 yen        40.00 yen  
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T